Document:EU EMEA/CHMP/313666/2005 - GUIDELINE ON THE EXPOSURE TO MEDICINAL PRODUCTS DURING PREGNANCY: NEED FOR POST-AUTHORISATION DATA 14-Nov-2005: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
gxplex>GxPlexBot Import from GxPlex Excel |
||
| Line 56: | Line 56: | ||
<noinclude> | <noinclude> | ||
== References == | == References == | ||
{| class="wikitable | {| class="wikitable" | ||
! Reference !! Scope !! Document part !! Language !! Preview | ! Reference !! Scope !! Document part !! Language !! Preview | ||
|- | |- | ||
Revision as of 15:06, 29 June 2026
| Document information | |
|---|---|
| Reference | EU EMEA/CHMP/313666/2005
- GUIDELINE ON THE EXPOSURE TO MEDICINAL PRODUCTS DURING PREGNANCY: NEED FOR POST-AUTHORISATION DATA 14-Nov-2005 |
| Validity area | EU |
| Scope(s) | HM |
| Document name | EMEA/CHMP/313666/2005
- GUIDELINE ON THE EXPOSURE TO MEDICINAL PRODUCTS DURING PREGNANCY: NEED FOR POST-AUTHORISATION DATA |
| Version / Revision | 14-Nov-2005 |
| Status | Current |
| Document type | Official guideline |
| Language(s) | EN |
| Description | EMEA/CHMP/313666/2005
COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EXPOSURE TO MEDICINAL PRODUCTS DURING PREGNANCY: NEED FOR POST-AUTHORISATION DATA |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
References
| Reference | Scope | Document part | Language | Preview |
|---|---|---|---|---|
| Reference:EU EMEA/CHMP/313666/2005 - GUIDELINE ON THE EXPOSURE TO MEDICINAL PRODUCTS DURING PREGNANCY: NEED FOR POST-AUTHORISATION DATA 14-Nov-2005 2.1 | HM | 2.1 | EN | 2.1 Background The majority of medicinal products or chemical substances administered to a pregnant woman could have effects on the foetus either before the placenta is fully developed or ... |
